These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25437696)

  • 1. [Sugammadex versus neostigmine in pediatric patients: a prospective randomized study].
    Kara T; Ozbagriacik O; Turk HS; Isil CT; Gokuc O; Unsal O; Seyhan E; Oba S
    Rev Bras Anestesiol; 2014; 64(6):400-5. PubMed ID: 25437696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial.
    Cappellini I; Picciafuochi F; Ostento D; Danti G; De Gaudio AR; Adembri C
    Trials; 2018 Feb; 19(1):135. PubMed ID: 29467022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
    Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of neostigmine and sugammadex on postoperative residual curarization and postoperative pulmonary complications by means of diaphragm and lung ultrasonography: a study protocol for prospective double-blind randomized controlled trial.
    Zhang YG; Chen Y; Zhang YL; Yi J
    Trials; 2022 May; 23(1):376. PubMed ID: 35526047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A discrete event simulation model of clinical and operating room efficiency outcomes of sugammadex versus neostigmine for neuromuscular block reversal in Canada.
    Insinga RP; Joyal C; Goyette A; Galarneau A
    BMC Anesthesiol; 2016 Nov; 16(1):114. PubMed ID: 27852231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
    Geldner G; Niskanen M; Laurila P; Mizikov V; Hübler M; Beck G; Rietbergen H; Nicolayenko E
    Anaesthesia; 2012 Sep; 67(9):991-8. PubMed ID: 22698066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular and Clinical Recovery in Thoracic Surgical Patients Reversed With Neostigmine or Sugammadex.
    Murphy GS; Avram MJ; Greenberg SB; Bilimoria S; Benson J; Maher CE; Teister KJ; Szokol JW
    Anesth Analg; 2021 Aug; 133(2):435-444. PubMed ID: 33323787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of rocuronium induced neuromuscular block with sugammadex or neostigmine: a large observational study.
    Della Rocca G; Pompei L; Pagan DE Paganis C; Tesoro S; Mendola C; Boninsegni P; Tempia A; Manstretta S; Zamidei L; Gratarola A; Murabito P; Fuggiano L; DI Marco P
    Acta Anaesthesiol Scand; 2013 Oct; 57(9):1138-45. PubMed ID: 23849107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sugammadex versus neostigmine for neuromuscular blockade reversal in outpatient surgeries: A randomized controlled trial to evaluate efficacy and associated healthcare cost in an academic center.
    Fiorda Diaz J; Echeverria-Villalobos M; Esparza Gutierrez A; Dada O; Stoicea N; Ackermann W; Abdel-Rasoul M; Heard J; Uribe A; Bergese SD
    Front Med (Lausanne); 2022; 9():1072711. PubMed ID: 36569123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Impact of Sugammadex in the Reversal of Neuromuscular Blockade.
    Goodner JA; Likar EJ; Hoff AL; Quedado JM; Kohli A; Ellison P
    Cureus; 2021 Jun; 13(6):e15413. PubMed ID: 34249560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients.
    Plaud B; Meretoja O; Hofmockel R; Raft J; Stoddart PA; van Kuijk JH; Hermens Y; Mirakhur RK
    Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Effects of Sugammadex and Neostigmine on Postoperative Neuromuscular Blockade Recovery in Patients with Interstitial Lung Diseases Undergoing Transbronchial Cryobiopsy: A Randomized Trial.
    Lu L; Chen X; Li S; Cen Y
    Med Sci Monit; 2024 May; 30():e942773. PubMed ID: 38689479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients.
    Woo T; Kim KS; Shim YH; Kim MK; Yoon SM; Lim YJ; Yang HS; Phiri P; Chon JY
    Korean J Anesthesiol; 2013 Dec; 65(6):501-7. PubMed ID: 24427455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block.
    Schaller SJ; Fink H; Ulm K; Blobner M
    Anesthesiology; 2010 Nov; 113(5):1054-60. PubMed ID: 20885293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized-controlled trial of sugammadex versus neostigmine: impact on early postoperative strength.
    Abola RE; Romeiser J; Rizwan S; Lung B; Gupta R; Bennett-Guerrero E
    Can J Anaesth; 2020 Aug; 67(8):959-969. PubMed ID: 32405975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center.
    Carron M; Baratto F; Zarantonello F; Ori C
    Clinicoecon Outcomes Res; 2016; 8():43-52. PubMed ID: 26937203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade.
    Cheong SH; Ki S; Lee J; Lee JH; Kim MH; Hur D; Cho K; Lim SH; Lee KM; Kim YJ; Lee W
    Korean J Anesthesiol; 2015 Dec; 68(6):547-55. PubMed ID: 26634077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.